| Aktie | Ticker | Breite | GCS | 2026/Q1 | 2025/Q4 | 2025/Q3 | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | Investment ($) | QoQ ($) | QoQ (%) | Anz. Fonds | ||||
| 631.967.061 $ | +60.479.590 $ | +70,7 % | 8 | 1.013.309.565 $ | +413.245.304 $ | +160,3 % | 12 | 526.684.974 $ | -50.881.170 $ | +49,4 % | 5 | ||||
| Terns Pharmaceuticals, Inc. | TERN | → 0 | 70.350.517 $ | -145.665.374 $ | -67,4 % | 1 | 216.015.891 $ | +164.228.839 $ | +317,1 % | 1 | 51.787.052 $ | +26.065.919 $ | +101,3 % | 1 | |
| Cidara Therapeutics, Inc. | → 0 | 211.318.836 $ | +85.736.778 $ | +68,3 % | 1 | 125.582.058 $ | +61.702.546 $ | +96,6 % | 1 | ||||||
| Erasca, Inc. | ERAS | → 0 | Neutral | 196.610.946 $ | +162.113.794 $ | +469,9 % | 1 | ||||||||
| SOLENO THERAPEUTICS INC | SLNO | → 0 | 41.434.287 $ | -112.572.236 $ | -73,1 % | 1 | 154.006.523 $ | -177.619.348 $ | -53,6 % | 1 | |||||
| Verona Pharma plc | VRNA | → 0 | 148.693.129 $ | +16.902.330 $ | +12,8 % | 1 | |||||||||
| Praxis Precision Medicines, Inc. | PRAX | → 0 | Neutral | 109.188.580 $ | +12.250.068 $ | +12,6 % | 1 | 96.938.512 $ | +86.397.077 $ | +819,6 % | 1 | ||||
| Cogent Biosciences, Inc. | COGT | → 0 | Neutral | 85.212.231 $ | +45.160.224 $ | +112,8 % | 1 | ||||||||
| Trevi Therapeutics, Inc. | TRVI | → 0 | Neutral | 60.779.389 $ | -3.005.854 $ | -4,7 % | 1 | 63.785.243 $ | +17.169.031 $ | +36,8 % | 1 | 46.616.212 $ | +22.067.383 $ | +89,9 % | 1 |
| AVADEL PHARMACEUTICALS PLC | AVDL | → 0 | 57.842.549 $ | +16.856.205 $ | +41,1 % | 1 | |||||||||
| DBV Technologies S.A. | DBVT | → 0 | Neutral | 55.725.516 $ | +8.536.146 $ | +18,1 % | 1 | 47.189.370 $ | +36.644.310 $ | +347,5 % | 1 | ||||
| Compass Therapeutics, Inc. | CMPX | → 0 | Neutral | 50.495.515 $ | -763.637 $ | -1,5 % | 1 | 51.259.152 $ | +17.850.021 $ | +53,4 % | 1 | ||||
| Dyne Therapeutics, Inc. | DYN | → 0 | Neutral | 51.148.618 $ | +18.069.374 $ | +54,6 % | 1 | ||||||||
| Abivax S.A. | ABVX | → 0 | Schwach | 48.454.076 $ | +17.949.081 $ | +58,8 % | 1 | ||||||||
| Tango Therapeutics, Inc. | TNGX | → 0 | Neutral | 45.077.998 $ | +25.986.647 $ | +136,1 % | 1 | ||||||||
| SAB Biotherapeutics, Inc. | SABS | → 0 | Neutral | 43.738.600 $ | +1.027.800 $ | +2,4 % | 1 | 42.710.800 $ | +19.756.600 $ | +86,1 % | 1 | ||||
| 631.967.061 $ | +60.479.590 $ | +70,7 % | 8 | 1.013.309.565 $ | +413.245.304 $ | +160,3 % | 12 | 526.684.974 $ | -50.881.170 $ | +49,4 % | 5 | ||||